Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22240353
Conclusion of this study
Concerning other measured parameters no significant changes were observed neither in placebo nor in RES group. Our results show that resveratrol improved left ventricle diastolic function, endothelial function, lowered LDL-cholesterol level and protected against unfavourable hemorheological changes measured in patients with coronary artery disease (CAD).
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
 Cardiovascular System |
